Treatment of sinusitis related chronic facial pain and headache with botulinum toxin

Details for Australian Patent Application No. 2004216904 (hide)

Owner Botulinum Toxin Research Associates, Inc.

Inventors Borodic, Gary E.; Acquadro, Martin

Agent FB Rice

Pub. Number AU-B-2004216904

PCT Pub. Number WO2004/078201

Priority 60/453,037 06.03.03 US

Filing date 8 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 24 December 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078201 Priority application(s): WO2004/078201

24 December 2009 Application Accepted

  Published as AU-B-2004216904

22 April 2010 Standard Patent Sealed

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216908-Oral insulin composition and methods of making and using thereof

2004216901-Treatment of chronic chalazion and hordeolum with botulinum toxin